Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Matthews, Paul R ^a   Eastwood, Sharon L ^a   Harrison, Paul J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN RELATED PROTEIN; BETA ACTIN; BRAIN PROTEIN; MESSENGER RNA; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; SUPERIOR CERVICAL GANGLION 10; THYMOSIN BETA10; UNCLASSIFIED DRUG; ACTIN;

ACTIN RELATED GENE; ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN REGION; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; MAJOR DEPRESSION; MALE; OLIGODENDROGLIA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SCHIZOPHRENIA; TISSUE DISTRIBUTION; VISUAL CORTEX; DEMOGRAPHY; DNA MICROARRAY; ESSENTIAL GENE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ACTINS; ADULT; BIPOLAR DISORDER; DEMOGRAPHY; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE EXPRESSION REGULATION; GENES, ESSENTIAL; HUMANS; MALE; MIDDLE AGED; MYELIN BASIC PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA; VISUAL CORTEX;

EID: 84861730615     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038211     Document Type: Article

References (74)

1. Harrison PJ, (1999) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122: 593-624.
2. Dorph-Petersen KA, Lewis DA, (2011) Stereological approaches to identifying neuropathology in psychosis. Biol Psychiatry 69: 113-126.
3. Harrison PJ, Lewis DA, Kleinman JE, (2011) Neuropathology of schizophrenia. In: Weinberger DR, Harrison PJ, editors. Schizophrenia. 3rd edition Oxford Wiley Blackwell pp. 372-392.
4. Weinberger DR, (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44: 660-669.
5. Harrison PJ, (2004) The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology 174: 151-162.
6. Lewis DA, Sweet RA, (2009) Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J Clin Invest 119: 706-716.
7. Tamminga CA, Stan AD, Wagner AD, (2010) The hippocampal formation in schizophrenia. Am J Psychiatry 167: 1178-1193.
8. Knable MB, Torrey EF, Webster MJ, Bartko JJ, (2001) Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull 55: 651-659.
9. Harrison PJ, Eastwood SL, (2001) Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 11: 508-519.
10. Hashimoto T, Arion D, Unger T, Maldonado-Aviles JG, Morris HM, et al. (2008) Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 13: 147-161.
11. Horvath S, Janka Z, Mirnics K, (2011) Analyzing schizophrenia by DNA microarrays. Biol Psychiatry 69: 157-162.
12. Sequeira PA, Martin MV, Vawter MP, (2012) The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol Dis 45: 23-36.
13. Selemon LD, Rajkowska G, Goldman-Rakic PS, (1995) Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 52: 805-818.
14. Dorph-Petersen KA, Pierri JN, Wu Q, Sampson AR, Lewis DA, (2007) Primary visual cortex volume and total neuron number are reduced in schizophrenia. J Comp Neurol 501: 290-301.
15. Burnet PW, Eastwood SL, Harrison PJ, (1996) 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 15: 442-455.
16. Eastwood SL, Harrison PJ, (1998) Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia. Neuroscience 86: 437-448.
17. Eastwood SL, Cairns NJ, Harrison PJ, (2000) Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex. Br J Psychiatry 176: 236-242.
18. Hashimoto T, Bazmi H, Mirnics K, Wu Q, Sampson A, Lewis DA, (2008) Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry 165: 479-489.
19. Katsel P, Davis KL, Haroutunian V, (2005) Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr Res 79: 157-173.
20. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH, (2000) The Stanley Foundation brain collection and neuropathology consortium. Schizophr Res 44: 151-155.
21. Chomczynski P, Sacchi N, (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
22. Kendziorski C, Irizarry RA, Chen KS, Haag JD, Gould MN, (2005) On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci USA 102: 4252-4257.
23. Lipska BK, Deep-Soboslay A, Weickert CS, Hyde TM, Martin CE, et al. (2006) Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia. Biol Psychiatry 60: 650-658.
24. Weickert CS, Sheedy D, Rothmond DA, Dedova I, Fung S, et al. (2010) Selection of reference gene expression in a schizophrenia brain cohort. Aust NZ J Psychiatry 44: 59-70.
25. Chen L, Segal DM, Mash DC, (1999) Semi-quantitative reverse-transcriptase polymerase chain reaction: an approach for the measurement of target gene expression in human brain. Brain Res Protocols 4: 132-139.
26. Burnet PWJ, Eastwood SL, Harrison PJ, (1994) Detection and quantitation of 5-HT1A and 5-HT2A receptor mRNAs in human hippocampus using a reverse transcriptase-polymerase chain reaction (RT-PCR) technique and their correlation with age and binding site densities. Neurosci Lett 178: 85-89.
27. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: 0034.
28. Tunbridge EM, Eastwood SL, Harrison PJ, (2011) Changed relative to what? Housekeeping genes and normalization strategies in human brain gene expression studies. Biol Psychiatry 69: 173-179.
29. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, et al. (2003) Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362: 798-805.
30. Campagnoni AT, Pribyl TM, Campagnoni CW, Kampf K, Amur-Umarjee S, et al. (1993) Structure and developmental regulation of Golli-mbp, a 105-kilobase gene that encompasses the myelin basic protein gene and is expressed in cells in the oligodendrocyte lineage in the brain. J Biol Chem 268: 4930-4938.
31. Kamholz J, Toffenetti J, Lazzarini RA, (1988) Organization and expression of the human myelin basic protein gene. J Neurosci Res 21: 62-70.
32. Aggarwal S, Yurlova L, Simons M, (2011) Central nervous system myelin: structure, synthesis and assembly. Trends Cell Biol 21: 585-593.
33. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, et al. (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98: 4746-4751.
34. Konradi C, Sillivan SE, Clay HB, (2012) Mitochondria, oligodendrocytes and inflammation in bipolar disorder: Evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dise 45: 37-47.
35. Karoutzou G, Emrich HM, Dietrich DE, (2008) The myelin-pathogenesis puzzle in schizophrenia: a literature review. Mol Psychiatry 13: 245-260.
36. Martins-de-Souza D, (2010) Proteome and transcriptome analysis suggests oligodendrocyte dysfunction in schizophrenia. J Psychiat Res 44: 149-156.
37. Lu ZF, Ku L, Chen Y, Feng Y, (2005) Developmental abnormalities of myelin basic protein expression in fyn knock-out brain reveal a role of Fyn in posttranscriptional regulation. J Biol Chem 280: 389-395.
38. Kramer-Albers E-M, White R, (2011) From axon-glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase. Cell Mol Life Sci 68: 2003-2012.
39. Tanaka J, Kira M, Sobue K, (1993) Gelsolin is localized in neuronal growth cones. Dev Brain Res 76: 268-271.
40. Weinberger R, Schevzov G, Jeffrey P, Gordon K, Hill M, et al. (1996) The molecular composition of neuronal microfilaments is spatially and temporally regulated. J Neurosci 16: 238-252.
41. Tanaka J, Sobue K, (1994) Localization and characterization of gelsolin in nervous tissues: gelsolin is specifically enriched in myelin-forming cells. J Neurosci 14: 1038-1052.
42. Mills JW, Mandel LJ, (1994) Cytoskeletal regulation of membrane transport events. Faseb J 8: 1161-1165.
43. Krucker T, Siggins GR, Halpain S, (2000) Dynamic actin filaments are required for stable long-term potentiation (LTP) in area CA1 of the hippocampus. Proc Natl Acad Sci USA 97: 6856-6861.
44. Matus A, (2000) Actin-based plasticity in dendritic spines. Science 290: 754-758.
45. Dunaevsky A, (2004) Connecting the dots: from actin polymerization to synapse formation. Neuron 44: 216-218.
46. Zito K, Knott G, Shepherd GM, Shenolikar S, Svoboda K, (2004) Induction of spine growth and synapse formation by regulation of the spine actin cytoskeleton. Neuron 44: 321-334.
47. Dillon C, Goda Y, (2005) The actin cytoskeleton: integrating form and function at the synapse. Annu Rev Neurosci 28: 25-55.
48. Matus A, Ackermann M, Pehling G, Byers HR, Fujiwara K, (1982) High actin concentrations in brain dendritic spines and postsynaptic densities. Proc Natl Acad Sci USA 79: 7590-7594.
49. Micheva KD, Vallee A, Beaulieu C, Herman IM, Leclerc N, (1998) beta-Actin is confined to structures having high capacity of remodelling in developing and adult rat cerebellum. Eur J Neurosci 10: 3785-3798.
50. Zhang W, Benson DL, (2002) Developmentally regulated changes in cellular compartmentation and synaptic distribution of actin in hippocampal neurons. J Neurosci Res 69: 427-436.
51. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, et al. (2004) Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61: 300-308.
52. Prabakaran S, Swatton J, Ryan M, Huffaker SJ, Huang J, et al. (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9: 684-697.
53. Eastwood SL, Lyon L, George L, Andrieux A, Job D, et al. (2007) Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice. J Psychopharmacol 21: 635-644.
54. Chubb JE, Brasdhaw NJ, Soares DC, Porteous DJ, Millar JK, (2008) The DISC locus in psychiatric illness. Mol Psychiatry 13: 36-64.
55. Halpain S, Hipolito A, Saffer L, (1998) Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J Neurosci 18: 9835-9844.
56. Lai WS, Xu B, Westphal KG, Paterlini M, Olivier B, et al. (2006) Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc Natl Acad Sci USA 103: 16906-16911.
57. Kubota K, Kumamoto N, Matsuzaki S, Hashimoto R, Hattori T, et al. (2009) Dysbindin engages in c-Jun N-terminal kinase activity and cytoskeletal organization. Biochem Biophys Res Commun 379: 191-195.
58. Lin Y-C, Koleske AJ, (2010) Mechanisms of synapse and dendrite maintenance and their disruption in psychiatric and neurodegenerative disorders. Annu Rev Neurosci 33: 349-378.
59. Kim S, Webster MJ, (2010) Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol Psychiatry 15: 326-336.
60. Lauriat TL, Dracheva S, Chin B, Schmeidler J, McInnes LA, et al. (2006) Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain. Neuroscience 137: 843-851.
61. Dean B, Keriakous D, Scarr E, Thomas EA, (2007) Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia. Aust NZ J Psychiatry 41: 308-320.
62. Silberberg G, Baruch K, Navon R, (2009) Detection of stable reference genes for real-time PCR analysis in schizophrenia and bipolar disorder. Anal Biochem 391: 91-97.
63. Sun HQ, Yin HL, (2007) The beta-thymosin enigma. Ann NY Acad Sci 1112: 45-55.
64. Sribenja S, Li M, Wongkham S, Wongkham C, Yao Q, et al. (2009) Advances in thymosin beta10 research: differential expression, molecular mechanisms, and clinical implications in cancer and other conditions. Cancer Invest 27: 1016-1022.
65. Carpintero P, Anadon R, Gomez-Marquez J, (1999) Expression of the thymosin beta10 gene in normal and kainic acid-treated rat forebrain. Mol Brain Res 70: 141-146.
66. Campagnoni C, Landry C, Pribyl T, Schonmann V, Kampf K, et al. (2001) Identification of genes in the oligo-dendrocyte lineage through the analysis of conditionally immortalized cell lines. Dev Neurosci 23: 452-463.
67. Hall AK, (1991) Developmental regulation of thymosin beta 10 mRNA in the human brain. Mol Brain Res 9: 175-177.
68. Border BG, Lin S, Griffin WS, Pardue S, Morrison-Bogorad M, (1993) Alterations in actin-binding β-thymosin expression accompany neuronal differentiation and migration in rat cerebellum. J Neurochem 61: 2104-2114.
69. Boggs JM, Rangaraj G, Heng YM, Liu YF, Harauz G, (2011) Myelin basic protein binds microtubules to a membrane surface and to actin filaments in vitro: Effect of phosphorylation and deimination. Biochim Biophys Acta Bioemembranes 1808: 761-773.
70. Bamm VV, De Avila M, Smith GST, Ahmed MAM, Harauz G, (2011) Structured functional domains of myelin basic protein: cross talk between actin polymerization and Ca(2+)-dependent calmodulin interaction. Biophys J 101: 1248-1256.
71. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, et al. (2005) Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 57: 252-260.
72. Shao L, Vawter MP, (2008) Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry 64: 89-97.
73. Harrison PJ, (2002) The neuropathology of primary mood disorder. Brain 125: 1428-1449.
74. Price JL, Drevets WC, (2012) Neural circuits underlying the pathophysiology of mood disorders. Trends Cogn Sci 16: 61-71.